Eterna Therapeutics
ERNA
HK$14.05
Share price
-5.79%
Change (1 day)
-0.64%
Change (1 year)
Categories
Eterna Therapeutics (ERNA) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : HK$86.41 Million
According to Eterna Therapeutics's latest financial reports the company's total liabilities are HK$86.41 Million. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Eterna Therapeutics - Total liabilities on balance sheet (from 2020 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | HK$27.7 M | -92.44% |
| 2023-12-31 | HK$0.36 B | 360.87% |
| 2022-12-31 | HK$79.47 M | 69.28% |
| 2021-12-31 | HK$46.94 M | 15.42% |
| 2020-12-31 | HK$40.67 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Baxter BAX | HK$111.85 B | 129,339.55% | 🇺🇸 USA |
 Geron GERN | HK$2.30 B | 2,572.47% | 🇺🇸 USA |
 Omeros Corporation OMER | HK$3.52 B | 3,975.88% | 🇺🇸 USA |
 Sanofi SNY | HK$488.07 B | 564,714.24% | 🇫🇷 France |
 Bio-Techne TECH | HK$4.91 B | 5,588.38% | 🇺🇸 USA |
 Genetic Technologies GENE | HK$22.88 M | -73.52% | 🇦🇺 Australia |
 Teva Pharmaceutical Industries TEVA | HK$252.32 B | 291,897.46% | 🇮🇱 Israel |